+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biosimilar"

Biosimilars Market Outlook, 2030 - Product Thumbnail Image

Biosimilars Market Outlook, 2030

  • Report
  • May 2025
  • 191 Pages
  • Global
From
Biosimilars Market Overview, 2025-30 - Product Thumbnail Image

Biosimilars Market Overview, 2025-30

  • Report
  • May 2025
  • 102 Pages
  • Global
From
Middle East & Africa Biosimilars Market Outlook, 2030 - Product Thumbnail Image

Middle East & Africa Biosimilars Market Outlook, 2030

  • Report
  • May 2025
  • 80 Pages
  • Middle East, Africa
From
South America Biosimilars Market Outlook, 2030 - Product Thumbnail Image

South America Biosimilars Market Outlook, 2030

  • Report
  • May 2025
  • 80 Pages
From
Asia-Pacific Biosimilars Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Biosimilars Market Outlook, 2030

  • Report
  • May 2025
  • 95 Pages
  • Asia Pacific
From
Europe Biosimilars Market Outlook, 2030 - Product Thumbnail Image

Europe Biosimilars Market Outlook, 2030

  • Report
  • May 2025
  • 96 Pages
  • Europe
From
North America Biosimilars Market Outlook, 2030 - Product Thumbnail Image

North America Biosimilars Market Outlook, 2030

  • Report
  • May 2025
  • 87 Pages
  • North America
From
From
US Biosimilar industry outlook to 2028 - Product Thumbnail Image

US Biosimilar industry outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Bioprocessing Markets and Forecast, 2023 - Product Thumbnail Image

Bioprocessing Markets and Forecast, 2023

  • Report
  • August 2023
  • 66 Pages
  • Global
From
From
Biosimilars World Market - Product Thumbnail Image

Biosimilars World Market

  • Report
  • January 2023
  • 28 Pages
  • Global
From
From
Loading Indicator

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers. Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more